The Collegium Internationale Allergologicum (CIA) was founded on 15 October 1954 in London by a group of 48 international allergists and immunologists from 18 countries of all continents, among them such distinguished scientists as Carl Prausnitz-Giles, Sir Henry Dale, Paul Kallos, and many others. Contrary to other international associations in the field, this Collegium limited the number of members in order to allow more intense and open discussions in “the humble spirit of scientific enquiry, friendly cooperation, good fellowship and professional relationships in the field of allergy” as stated in the statutes. It is not possible to apply for membership, and one has to be proposed by at least 2 CIA members and invited to present at least once at a symposium. Over the decades, a rhythm of biannual symposia developed, the 32nd held in Palma de Mallorca in October 2018. These symposia went around the world from London, Rome, Copenhagen, New Orleans, Puerto Vallarta, Nantucket, Hakone, Konstanz, Goeteborg, and Sorrento, just to name a few places. Preferably they were held on islands such as Capri, Corfu, Martinique, Curacao, Bornholm, Malta, and Ischia in order to make it more difficult for people to arrive late or leave early. It is expected that participants stay over the whole length of the 5-day symposium. On these symposia, it is good custom to also present unpublished data, so participants get the latest news. The most important developments in the field of Allergy and Clinical Immunology have been discussed at early stage and sometimes by speakers who later won the Nobel Prize. While all presentations are equal, be it oral communications or posters, there are 3 special lectures, namely the Carl Prausnitz lecture, the Paul Kallos lecture, and a “Relaxing from Immunology” lecture which can be devoted to any interesting topic not necessarily related to medicine or allergy. Since many years, the contents of the symposium are published in a proceedings volume, over a longtime printed within the “International Archives of Allergy and Immunology” which until now is the official journal of the Collegium. Participants agree that in the flood of more and more scientific congresses and larger events, the CIA Symposia are unique in their openness and friendly scientific interchange.

Keywords:
Collegium Internationale allergologicum, History, Symposia, Allergy, Immunology
1.
Bergmann KC, Ring J, editors.
History of allergy
. Basel: Karger; 2014.
2.
Ring J, De Weck A, editors.
CIA – Collegium Internationale Allergologicum devoted to allergy research 1954–2006
. 2nd ed. Munich: Urban & Vogel; 2006.
3.
Bienenstock J, Ring J, Togias A, editors. Allergy frontiers and futures.
Allergy Clin Immunol Int
. 2014;(Suppl 1).
4.
Bochner B, Creticos P, editors.
Towards precision diagnosis and targeted intervention in allergic disease
. Pisa: Pacini Editore; 2018.
5.
Harley D, Kallos P, editors. Aspects of allergy research.
Int Arch Allergy Appl Immunol
. 1955.
6.
Kraft D, Grubeck-Loebenstein B, Wick G, Ring J, editors. Allergy: a disease of modern society.
Int Arch Allergy Immunol
. 1997;113.
7.
Marone G, Triggiani M, Genovese A, editors.
Translational science:
from basic to clinical immunology and allergy
. Pisa: Pacini Editore; 2012.
8.
Maurer M, Behrendt H, Galli S, editors.
Allergies:
current challenges and solutions
. Pisa: Pacini Editore; 2016.
9.
Rother KO, De Weck A, editors. Monographs in allergy. In:
Mediators of immediate type inflammatory reactions
. Basel: Karger; 1977. Vol. 12.
10.
van Ree R, Ring J, editors.
Environmental and genetic factors in allergy and clinical immunology
. Pisa: Pacini Editore; 2010.
© 2021 S. Karger AG, Basel
2021
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.